Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Inflammation 2Frailty 2Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Prostatic Neoplasms 1Papillomavirus Infections 1Liver Neoplasms 1Liver Cirrhosis 1Leiomyoma 1Esophageal Neoplasms 1Deglutition Disorders 1Carcinoma, Hepatocellular 1Atypical Squamous Cells of the Cervix 1

Interventions

Papillomavirus Vaccines 2Imiquimod 2GX-188 vaccine 2Celecoxib 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2poly(gamma-glutamic acid) 1pembrolizumab 1nimotuzumab 1epigallocatechin gallate 1artesunic acid 1artemisinin 1Sutures 1Progesterone 1Pemetrexed 1Omeprazole 1Ointments 1Ocoxin 1Nelfinavir 1Lighting 1Indomethacin 1IRX 2 1Hepatitis B Vaccines 1Geritol 1GPI0100 1Folic Acid 1Eflornithine 1Cyclophosphamide 1Conization 1Cisplatin 1Chemoprevention 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Uterine Cervical Dysplasia × epigallocatechin gallate × Clear all
NCT07572396 2026-05-14

Phase II Study of Dysplasixâ„¢ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Amplexd Therapeutics, Inc.

Phase 2 Recruiting
45 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡